Vimarsana
Biggest News Aggregation in the World

Page 32 - Eric Cohen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Cohen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Cohen Today - Breaking & Trending Today

SDSU Captures Bragging Rights and Win Against USD - Vimarsana News

SDSU Captures Bragging Rights and Win Against USD

The South Dakota State University and University of South Dakota rivalry has another chapter after Saturdays game in Brookings.

Source: kxrb.com
Riverhead Police host Coffee with a Cop Day - Vimarsana News

Riverhead Police host Coffee with a Cop Day

Riverhead police officers greeted residents at four locations across town this morning for the annual Coffee with a Cop Day, an event held on this day across…

Soros's Open Society Foundation Gives Millions to Pro-Amnesty Groups - Vimarsana News

Soros's Open Society Foundation Gives Millions to Pro-Amnesty Groups

George Soros’s Open Society Foundation donated millions of dollars to organizations dedicated to advocating for mass immigration and amnesty.

End-of-Life Care: Expanding Patient Choice of Ethical Options - Vimarsana News

End-of-Life Care: Expanding Patient Choice of Ethical Options

End-of-life care issues are complex and difficult, and in the realm of public policy—where a zero-sum game over ethical alternatives is the norm—these issues can further divide an already polarized nation. Too often, partisans frame the national debate as if the only choice were between patients receiving drastic interventions (such as being hooked up to a machine that artificially extends life indefinitely) or allowing physicians to assist in the suicides of their patients. There is, however, a wide area between these two extreme options.

PCSK9 Inhibitor Passes Muster for LDL Reduction in Acute Coronary Syndrome - Vimarsana News

PCSK9 Inhibitor Passes Muster for LDL Reduction in Acute Coronary Syndrome

Question now is whether routine early treatment will translate to better clinical outcomes